Engineering Anti-Cancer Nanovaccine Based on Antigen Cross-Presentation

Bioscience Reports - Netherlands
doi 10.1042/bsr20193220
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Current Concepts of Antigen Cross-Presentation

Frontiers in Immunology
AllergyImmunology
2018English

Correction: Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

Journal of Immunology
AllergyImmunology
2014English

Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer

Frontiers in Immunology
AllergyImmunology
2014English

The MARCH Family Joins the Antigen Cross-Presentation Party

Immunology and Cell Biology
AllergyImmunologyCell Biology
2017English

The Role of Heat Shock Proteins in Antigen Cross Presentation

Frontiers in Immunology
AllergyImmunology
2012English

Scavenger Receptors and Heat-Shock Protein-Mediated Antigen Cross-Presentation

Biochemical Society Transactions
Biochemistry
2004English

Engineering HIV-Resistant, Anti-Hiv Chimeric Antigen Receptor T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2017English

Antibody-Enhanced Cross-Presentation of Self Antigen Breaks T Cell Tolerance

Journal of Clinical Investigation
Medicine
2007English

Artificially Cloaked Viral Nanovaccine for Cancer Immunotherapy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy